Stempoint Capital LP’s holdings in Johnson & Johnson were worth $3,768,000 at the end of the most recent reporting period. Check Out Our Latest Stock Report on JNJMore Johnson & Johnson NewsHere are the key news stories impacting Johnson & Johnson this week:Positive Sentiment: Expansion into next-generation oncology. Johnson & Johnson has a 52 week low of $164.23 and a 52 week high of $274.90. Johnson & Johnson Announces DividendThe business also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. See AlsoReceive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.